PFG Advisors Purchases 1,876 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

PFG Advisors increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,322 shares of the healthcare conglomerate's stock after buying an additional 1,876 shares during the quarter. PFG Advisors' holdings in UnitedHealth Group were worth $5,930,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Kapitalo Investimentos Ltda bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $41,000. Finally, Copia Wealth Management bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $42,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director owned 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 109,408 shares of company stock worth $31,607,768 over the last quarter. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $282.04 on Tuesday. The company has a 50-day moving average of $304.47 and a two-hundred day moving average of $432.39. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market cap of $255.85 billion, a price-to-earnings ratio of 11.81, a PEG ratio of 1.38 and a beta of 0.45. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.13%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their price objective for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. KeyCorp lowered their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. Finally, UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $394.43.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.